Biology Reference
In-Depth Information
Marchi, A., Munstermann, L.E., 1987. The mosquitoes of Sardinia: species records 35 years
after the malaria eradication campaign. Med. Vet. Entomol. 1 (1), 89-96.
Matthys, B., Sherkanov, T., Karimov, S.S., Khabirov, Z., Mostowlansky, T., Utzinger, J., et al.,
2008. History of malaria control in Tajikistan and rapid malaria appraisal in an agro-
ecological setting. Malar. J. 7, 217.
Mayxay, M., Pukrittayakamee, S., Newton, P.N., White, N.J., 2004. Mixed-species malaria
infections in humans. Trends Parasitol. 20 (5), 233-240.
Meissner, P.E., Mandi, G.,Witte, S., Coulibaly, B., Mansmann, U., Rengelshausen, J., et al., 2005.
Safety of the methylene blue plus chloroquine combination in the treatment of uncom-
plicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841].
Malar. J. 4, 45.
Meissner, P.E., Mandi, G., Coulibaly, B., Witte, S., Tapsoba, T., Mansmann, U., et al., 2006.
Methylene blue for malaria in Africa: results from a dose-finding study in combination
with chloroquine. Malar. J. 5, 84.
Meister, S., Plouffe, D.M., Kuhen, K.L., Bonamy, G.M., Wu, T., Barnes, S.W., et al., 2011.
Imaging of
Plasmodium
liver stages to drive next-generation antimalarial drug discov-
ery. Science 334 (6061), 1372-1377.
Mendes, C., Dias, F., Figueiredo, J., Mora,V.G., Cano, J., de Sousa, B., et al., 2011. Duffy nega-
tive antigen is no longer a barrier to
Plasmodium vivax
- molecular evidences from the
African West Coast (Angola and Equatorial Guinea). PLoS Negl. Trop. Dis. 5 (6), e1192.
Miller, M., 1955. Suppression of malaria by monthly drug administration. Am. J. Trop. Med.
Hyg. 4, 790-799.
Miller, M., 1956. Further studies on malaria suppression by monthly drug administration.
Am. J. Trop. Med. Hyg. 5, 624-637.
Moonen, B., Cohen, J.M., Snow, R.W., Slutsker, L., Drakeley, C., Smith, D.L., et al., 2010.
Operational strategies to achieve and maintain malaria elimination. Lancet 376 (9752),
1592-1603.
Moss, W.J., Norris, D.E., Mharakurwa, S., Scott, A., Mulenga, M., Mason, P.R., et al., 2011.
Challenges and prospects for malaria elimination in the Southern Africa region. Acta.
Trop.
Nasveld, P., Kitchener, S., Edstein, M., Rieckmann, K., 2002. Comparison of tafenoquine
(WR238605) and primaquine in the post-exposure (terminal) prophylaxis of vivax
malaria in Australian Defence Force personnel. Trans. R. Soc. Trop. Med. Hyg. 96 (6),
683-684.
Oh, M.D., Shin, H., Shin, D., Kim, U., Lee, S., Kim, N., et al., 2001. Clinical features of vivax
malaria. Am. J. Trop. Med. Hyg. 65 (2), 143-146.
Over, M., Bakote'e, B., Velayudhan, R., Wilikai, P., Graves, P.M., 2004. Impregnated nets or
DDT residual spraying? Field effectiveness of malaria prevention techniques in Solomon
Islands, 1993-1999. Am. J. Trop. Med. Hyg. 71 (Suppl. 2), 214-223.
Park, J.W., Jun, G., Yeom, J.S., 2009.
Plasmodium vivax
malaria: status in the Republic of
Korea following reemergence. Korean J. Parasitol. (Suppl. 47), S39-S50.
Plowe, C.V., Alonso, P., Hoffman, S.L., 2009. The potential role of vaccines in the elimination
of falciparum malaria and the eventual eradication of malaria. J. Infect. Dis. 200 (11),
1646-1649.
Polley, S.D., McRobert, L., Sutherland, C.J., 2004.Vaccination for vivax malaria: targeting the
invaders. Trends Parasitol. 20 (3), 99-102.
Ponsa, N., Sattabongkot, J., Kittayapong, P., Eikarat, N., Coleman, R.E., 2003. Transmission-
blocking activity of tafenoquine (WR-238605) and artelinic acid against naturally cir-
culating strains of
Plasmodium vivax
in Thailand. Am. J. Trop. Med. Hyg. 69 (5), 542-547.
Rajakaruna, R.S., Alifrangis, M., Amerasinghe, P.H., Konradsen, F., 2010. Pre-elimination
stage of malaria in Sri Lanka: assessing the level of hidden parasites in the population.
Malar. J. 9, 25.
